Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients.

Aslan I, Kucuksayan E, Aslan M.

Lipids Health Dis. 2013 Apr 24;12:54. doi: 10.1186/1476-511X-12-54.

2.

Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.

Ozturk OH, Can Y, Yonden Z, Motor S, Oktay G, Kaya H, Aslan M.

Lipids. 2013 Dec;48(12):1217-26. doi: 10.1007/s11745-013-3849-4.

PMID:
24113910
3.

Early postoperative changes of HDL subfraction profile and HDL-associated enzymes after laparoscopic sleeve gastrectomy.

Doğan S, Aslan I, Eryılmaz R, Ensari CO, Bilecik T, Aslan M.

Obes Surg. 2013 Dec;23(12):1973-80. doi: 10.1007/s11695-013-1011-2.

PMID:
23760763
5.

Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.

Hughes TA, Gaber AO, Amiri HS, Wang X, Elmer DS, Winsett RP, Hathaway DK, Hughes SM, Ghawji M.

Metabolism. 1994 Mar;43(3):333-47.

PMID:
8139482
6.
8.

Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.

Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P.

Arterioscler Thromb. 1993 Jun;13(6):815-25.

9.
10.

Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner.

Brousseau ME, Santamarina-Fojo S, Vaisman BL, Applebaum-Bowden D, Bérard AM, Talley GD, Brewer HB Jr, Hoeg JM.

J Lipid Res. 1997 Dec;38(12):2537-47.

11.

Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.

Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin GH.

Atherosclerosis. 2000 Feb;148(2):283-91.

PMID:
10657563
12.

LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.

Ambrosch A, Mühlen I, Kopf D, Augustin W, Dierkes J, König W, Luley C, Lehnert H.

Diabetes Care. 1998 Dec;21(12):2077-84.

PMID:
9839097
13.

Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients.

Kimak E, Bylina J, Solski J, Hałabiś M, Baranowicz-Gąszczyk I, Książek A.

Cell Biochem Biophys. 2013 Nov;67(2):695-702. doi: 10.1007/s12013-013-9559-y.

14.
15.
16.

Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, decreases cholesteryl ester transfer protein in type 2 diabetes mellitus.

Yagyu H, Nagashima S, Takahashi M, Miyamoto M, Okada K, Osuga J, Ishibashi S.

Endocr J. 2012;59(12):1077-84.

17.

Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins.

Liang HQ, Rye KA, Barter PJ.

J Lipid Res. 1994 Jul;35(7):1187-99.

18.
19.

Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.

Gugliucci A.

Clin Chim Acta. 2014 Feb 15;429:38-45. doi: 10.1016/j.cca.2013.11.021.

PMID:
24280342

Supplemental Content

Support Center